Sequenom Inc (SQNM)

2.39
0.01 0.42
NASDAQ : Health Care
Prev Close 2.40
Open 2.39
Day Low/High 2.39 / 2.40
52 Wk Low/High 0.82 / 3.10
Volume 2.05M
Avg Volume 2.19M
Exchange NASDAQ
Shares Outstanding 119.24M
Market Cap 284.99M
EPS -0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)
Brocade, Rigel, ARM: Early Volume Plays

Brocade, Rigel, ARM: Early Volume Plays

Several stocks trading under $10 were poised to move on above-average volume during Tuesday's session.

Biotech Stock Mailbag: NexMed

Biotech Stock Mailbag: NexMed

Biotech watchdog Adam Feuerstein answers readers' questions about NexMed, Cell Therapeutics and other news-worthy stocks.

Exact Sciences Finds its Mojo

Exact recaptures Wall Street's interest as the firm gets closer to developing a commercially successful screening test for colon cancer.

Sequenom, FalconStor: Early Volume Plays

Sequenom, FalconStor: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Friday's session.

Biotech's 2009 Movers & Shakers: BioBuzz

A look back at 2009's best- and worst-performing bitoech stocks.

Three Ways to Play the January Effect

Small-caps and underdogs often outperform as the calendar flips over -- here's how you can take advantage.

Sequenom, Delta Petroleum: Early Volume Plays

Sequenom, Delta Petroleum: Early Volume Plays

Several stocks trading near $5 were poised to move on above-average volume during Thursday's session.

Sequenom, Avanir: Early Volume Plays

Sequenom, Avanir: Early Volume Plays

Several stocks trading under $10 -- including Sequenom, Avanir and Netlist -- were poised to move on above-average volume during Wednesday's session.

Clarient, Sequenom: Early Volume Plays

Clarient, Sequenom: Early Volume Plays

Several stocks trading under $5 were poised to move on above-average volume during Monday's session.

Incyte, Sequenom: Early Volume Plays

Incyte, Sequenom: Early Volume Plays

Several stocks trading under $10 were poised to move on above-average volume during Monday's session.

Sequenom 3Q Loss Widens On Higher Costs, Sales Dip

Sequenom 3Q Loss Widens On Higher Costs, Sales Dip

Sequenom's 3rd-quarter loss widens on higher expenses, lower revenue

Midday Movers: Pump Up the Volume

Midday Movers: Pump Up the Volume

Several small-cap stocks were moving on above-average volume during Thursday's session.

Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz

Mannkind Falls on Talk of Partner, FDA Delay: BioBuzz

Company is delaying partnership talks for inhaled insulin product.

No Lupus Confab Invite for Immunomedics: BioBuzz

No Lupus Confab Invite for Immunomedics: BioBuzz

Epratuzumab data won't be presented at next week's rheumatology meeting.

Walgreen, Gannett, Warner Music Group Big Movers

Walgreen, Gannett, Warner Music Group Big Movers

Walgreen, Gannett, Warner Music Group, Sequenom, CIT Group are among big market movers Tuesday

Sequenom Tumbles After Execs Fired Amid Test Woes

Sequenom Tumbles After Execs Fired Amid Test Woes

Sequenom shares dive after CEO, other execs fired after mishandling of medical test results

A Sale May Be Sequenom's Only Option

A Sale May Be Sequenom's Only Option

Launching a successful prenatal genetic test for Down syndrome may be beyond Sequenom's reach.

Sequenom Study Found Unreliable

Sequenom Study Found Unreliable

An investigation of Sequenom's study methods finds the firm's data was unreliable and misreported, leading to an executive purging.

'Mad Money Lightning Round': Go With Crown Holdings

'Mad Money Lightning Round': Go With Crown Holdings

Cramer loves the packaging space, especially Crown Holdings, which he calls a winner.

Cramer's 'Mad Money' Recap: The Real Health Care Play (Final)

Cramer's 'Mad Money' Recap: The Real Health Care Play (Final)

Cramer says investors should pay more attention on the swine-flu trade than Obama's health care overhaul. Click for news from Jim Cramer.

FDA Panel Rejects Vion Leukemia Drug

Concerned about safety, panel asks for another trial to be conducted

Bulls Bet on Kraft, Sequenom: Options Recap

Bulls Bet on Kraft, Sequenom: Options Recap

Traders are placing bullish bets on Kraft Foods and biotech firm Sequenom, OptionMonster says.

Today's Lists on Stockpickr: Aug. 31

Today's Lists on Stockpickr: Aug. 31

Here's what stood out in the market today.

Bulls Target Sequenom on Test Optimism

Bullish traders are expecting positive news about Sequenom's Down Syndrome test.

Biotech Stock Mailbag: Geron, Oculus, BioSante

Biotech Stock Mailbag: Geron, Oculus, BioSante

Geron, Oculus, BioSante, Gilead Sciences and Sequenom are among readers' stocks of interest in this special edition mailbag.

Vanda, Oculus, Sequenom: Biotech Notebook

Vanda Pharmaceuticals can't find a buyout partner; Oculus Innovative Sciences backs off drug claims; Sequenom walks back expectations for its Downs syndrome gene test.

Biotech's Hot and Getting Hotter

Biotech's Hot and Getting Hotter

July and August are traditionally slow months on the biotech calendar. But not this year as biotech firms, both big and small, release results from clinical trials or await FDA decisions.

Stockpickr's Charts of the Day: Nasdaq Stocks

Stockpickr's Charts of the Day: Nasdaq Stocks

Here's a look at the charts of Nasdaq stocks such as Cheesecake Factory and BioCryst.

Option Recap: CB Richard Attracts Bulls

Option Recap: CB Richard Attracts Bulls

Bullish traders are jumping on CB Richard Ellis stock and options after a hedge fund said it would buy shares.

Heavy Call Options Activity in Sequenom

Heavy Call Options Activity in Sequenom

Sequenom options were active Tuesday with more than 86,000 calls traded, dwarfing the average call turnover of 2,600 in the last month.